| Summary: | This is one of the few medical genetics texts on a 2-year revision cycle. It provides up-to-date information that can be read, retained, and applied with ease! The 3rd Edition covers pharmacogenomics, the societal implications of technologies, the Human Genome Project, cloning, genetic enhancement, and embryonic stem cell research, new tumor suppressor genes and oncogenes, and more. Mini-summaries, study questions, suggested readings, and a detailed glossary facilitate review of the material. Clinical relevance is demonstrated in over 230 photographs, illustrations, and tables as well as boxes containing patient/family vignettes. Its coverage includes ethical, legal, and social issues and clinical commentary on important genetic diseases. A companion web site offers continuing updates and a wealth of additional features. Features mini-summaries that appear in bold throughout each chapter. Supplies study questions and suggested readings at the end of each chapter. Contains a detailed glossary at the end of the book. Offers Clinical Commentary boxes that present detailed coverage of the most important genetic diseases and provide examples of modern clinical management. Demonstrates clinical relevance with boxed patient/family vignettes and coverage of ethical, legal, and social issues. Provides visual reinforcement and easy access to key information with over 230 photographs, illustrations, and tables. Includes a companion website with continuing content updates, additional clinical images, and more! Explores new technologies, including microarrays (e.g., DNA chips) and PCR-free detection of polymorphisms. Offers new material on pharmacogenomics, a field of study based on the principles of pharmacogenetics where genetic variation is assessed in order to predict a patient's response to specific drugs, including potential adverse reactions. Includes a new chapter, Genetics and Society, that discusses privacy, discrimination, and the societal implications of new genetic technologies Devotes a new section to the advances made possible by The Human Genome Project, such as the use of genomics databases to identify disease-causing genes. Contains a new section on Human Cloning, Genetic Enhancement, and Embryonic Stem Cell Research. Updates the Cancer Genetics chapter with information on new tumor suppressor genes and oncogenes, including discussion of their roles in carcinogenesis Expands the section, The Genetics of Common Diseases, with new information on genes predisposing to hypertension, type 2 diabetes, Alzheimer's disease, obesity, heart disease, and stroke.
|
|---|
